Benzocaine hydrochloride|cas 23239-88-5

Cas No.:	23239-88-5
Chemical Name:	Benzocaine hydrochloride
Synonyms:	Benzocaine hydrochloride;Benzocaine.HCl;ETHYL 4-AMINOBENZOATE HYDROCHLORIDE;BENZOCAINE HCL;4-Amino-benzoesaeure-aethylester,Hydrochlorid;4-amino-benzoic acid ethyl ester,hydrochloride;Benzoic acid,4-amino-,ethyl ester,hydrochloride;Ethyl p-aminobenzoate hydrochloride;ethyl 4-aminobenzoate,hydrochloride;23239-88-5;DTXCID10100303;ethyl 4-aminobenzoate;hydrochloride;Benzocaine (hydrochloride);DTXSID50177812;CCG-266593;105931-72-4;AC-8125;4-(Ethoxycarbonyl)anilinium chloride;AKOS015964248;Neutracaine;SCHEMBL944986;NSC 122792;Hydrochloride, Benzocaine;s4669;AS-76582;Benzoic acid, 4-amino-, ethyl ester, hydrochloride;AMBEN ETHYL ESTER HYDROCHLORIDE;Benzoic acid, 4-amino-, ethyl ester, hydrochloride (1:1);BENZOCAINE HYDROCHLORIDE [WHO-DD];FT-0638309;Q-200689;EN300-8152765;NSC122792;BENZOIC ACID, P-AMINO-, ETHYL ESTER, HYDROCHLORIDE;Ethyl4-aminobenzoatehydrochloride;CS-0030766;UNII-OG625Z9LEO;Q27285637;OG625Z9LEO;NSC-122792;E79058;SY293207;DB-046109;MFCD00012999
SMILES:	Cl.O(CC)C(C1C=CC(=CC=1)N)=O
Formula:	C₉H₁₂ClNO₂
M.Wt:	201.65
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.